Patents by Inventor Robert Luo

Robert Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250106355
    Abstract: Apparatuses, systems, and techniques to process image frames. In at least one embodiment, one or more intermediate video frames are generated between a first video frame and a second video frame. In at least one embodiment, the one or more intermediate video frames are generated based, at least in part, on depth information of one or more pixels of the first video frame or second video frame.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 27, 2025
    Inventors: Zhekun Luo, Robert Thomas Pottorff, Karan Sapra, Jarmo Rafael Lunden, Andrew J. Tao, Bryan Christopher Catanzaro
  • Patent number: 12258791
    Abstract: The present aspects include a magnetic detacher including a housing having a wall that defines a nest configured to receive a security tag; a gate member and an actuator configured to move the gate member between a closed position and an open position, wherein the gate member in the closed position blocks the nest, and in the open position allows access to the nest; a magnet positioned on an opposite side of the housing relative to the nest and adjacent to the nest, the magnet having a field in an area of the nest sufficient to unlock a magnetic lock of the security tag; and a processor in communication with the actuator and with a transaction system, wherein the processor is configured to control the actuator to move the gate member from the closed position to the open position based on receipt of an unlock signal from the transaction system.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: March 25, 2025
    Assignee: Sensormatic Electronics, LLC
    Inventors: Robert K. Lynch, Sergio M. Perez, Andrew J. Proulx, Michael del Busto, Channing E. Miller, Jose D. Garzon, Charles T. Turgeon, Danhui Luo, Marco R. Grimaldo
  • Publication number: 20250092039
    Abstract: The present disclosure relates to novel pan-KRAS glutarimide-containing compounds with KRAS degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment diseases and conditions.
    Type: Application
    Filed: October 18, 2024
    Publication date: March 20, 2025
    Inventors: Robert LUO, Ji LIU, Pin HUANG, Jie SU, Yan FENG, Ke LIU, Jie FAN, Wei HE, Yimin QIAN
  • Publication number: 20250065894
    Abstract: Systems and methods described herein include implementation of road surface-based localization techniques for advanced vehicle features and control methods including advanced driver assistance systems (ADAS), lane drift detection, passing guidance, bandwidth conservation and caching based on road data, vehicle speed correction, suspension and vehicle system performance tracking and control, road estimation calibration, and others.
    Type: Application
    Filed: December 29, 2022
    Publication date: February 27, 2025
    Applicant: ClearMotion, Inc.
    Inventors: Chenghui Luo, Marco Giovanardi, Stefan Schulze, John Parker Eisenmann, William Graves, Marcus Joseph Proctor, Nikolaos Karavas, Allen Chung-Hao Chen, Jack A. Ekchian, Hou-Yi Lin, Timothy Cotgrove, Robert Casey
  • Patent number: 12195459
    Abstract: The present disclosure relates to novel pan-KRAS glutarimide-containing compounds with KRAS degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment diseases and conditions.
    Type: Grant
    Filed: April 24, 2024
    Date of Patent: January 14, 2025
    Assignee: Tiger Biotherapeutics Inc.
    Inventors: Robert Luo, Ji Liu, Pin Huang, Jie Su, Yan Feng, Ke Liu, Jie Fan, Wei He, Yimin Qian
  • Publication number: 20250002473
    Abstract: The present disclosure relates to at least one entity chosen from a compound of Formula (I), tautomers, stereoisomers or a mixture of stereoisomers, hydrates, and deuterated derivatives thereof, and pharmaceutically acceptable salts of any of the foregoing, and their use as epidermal growth factor receptor (EGFR) degraders for the prevention and treatment of diseases and conditions, e.g., cancer. The present disclosure also relates to pharmaceutical compositions containing such entities, and their use in treating or preventing a disease or disorder associated with EGFR.
    Type: Application
    Filed: June 14, 2024
    Publication date: January 2, 2025
    Applicant: Accutar Biotechnology Inc.
    Inventors: Ji LIU, Pin HUANG, Ke LIU, Wei HE, Yimin QIAN, Jie FAN, Robert Luo
  • Patent number: 12168058
    Abstract: The present disclosure relates to novel glutarimide-containing compounds with KRAS mutant form degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of diseases and conditions.
    Type: Grant
    Filed: November 30, 2023
    Date of Patent: December 17, 2024
    Assignee: Tiger Biotherapeutics, Inc.
    Inventors: Ji Liu, Robert Luo, Pin Huang, Jie Su, Yan Feng, Ke Liu, Jie Fan, Wei He, Yimin Qian
  • Publication number: 20240398805
    Abstract: The disclosure provides quinazoline based compounds and pharmaceutical compositions thereof, which are useful for inhibiting EGFR, as well as methods for using such compounds to treat cancer associated with an EGFR or HER2 exon 20 insertion mutation.
    Type: Application
    Filed: February 4, 2022
    Publication date: December 5, 2024
    Applicant: ACCUTAR BIOTECHNOLOGY INC.
    Inventors: Yimin Qian, Wei HE, Robert LUO, Jie Fan
  • Patent number: 12110291
    Abstract: The present disclosure relates to novel pan-KRAS glutarimide-containing compounds with KRAS degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment diseases and conditions.
    Type: Grant
    Filed: November 30, 2023
    Date of Patent: October 8, 2024
    Assignee: Tiger Biotherapeutics Inc.
    Inventors: Robert Luo, Ji Liu, Pin Huang, Jie Su, Yan Feng, Ke Liu, Jie Fan, Wei He, Yimin Qian
  • Publication number: 20240294527
    Abstract: The present disclosure relates to novel pan-KRAS glutarimide-containing compounds with KRAS degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment diseases and conditions.
    Type: Application
    Filed: April 24, 2024
    Publication date: September 5, 2024
    Inventors: Robert LUO, Ji LIU, Pin HUANG, Jie SU, Yan FENG, Ke LIU, Jie FAN, Wei HE, Yimin QIAN
  • Publication number: 20240217972
    Abstract: The present disclosure relates to novel pan-KRAS glutarimide-containing compounds with KRAS degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment diseases and conditions.
    Type: Application
    Filed: November 30, 2023
    Publication date: July 4, 2024
    Inventors: Robert LUO, Ji LIU, Pin HUANG, Jie SU, Yan FENG, Ke LIU, Jie FAN, Wei HE, Yimin QIAN
  • Publication number: 20240216516
    Abstract: The present disclosure relates to novel glutarimide-containing compounds with KRAS mutant form degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of diseases and conditions.
    Type: Application
    Filed: November 30, 2023
    Publication date: July 4, 2024
    Inventors: Ji LIU, Robert LUO, Pin HUANG, Jie SU, Yan FENG, Ke LIU, Jie FAN, Wei HE, Yimin QIAN
  • Publication number: 20240132502
    Abstract: The present disclosure relates to novel compounds that degrade Bruton's tyrosine kinase (BTK), pharmaceutical compositions containing such compounds, and their use in prevention and treatment of conditions modulated by BTK.
    Type: Application
    Filed: February 2, 2022
    Publication date: April 25, 2024
    Applicant: ACCUTAR BIOTECHNOLOGY INC.
    Inventors: Yimin Qian, Wei HE, Robert LUO, Jie SU, Hui ZHANG, Ke LIU, Jie FAN
  • Publication number: 20240051940
    Abstract: The disclosure provides sulfonamides based compounds and pharmaceutical compositions thereof, which are useful for inhibiting one or more mutations of EGFR, as well as methods for using such compounds to treat cancer associated with EGFR mutations.
    Type: Application
    Filed: February 7, 2022
    Publication date: February 15, 2024
    Applicant: ACCUTAR BIOTECHNOLOGY INC.
    Inventors: Yimin QIAN, Robert LUO, Wei HE, Jie Fan
  • Patent number: 11530222
    Abstract: The present disclosure relates to novel compounds of Formula (I) that degrade Bruton's tyrosine kinase (BTK), pharmaceutical compositions containing such compounds, and their use in prevention and treatment of conditions modulated by BTK.
    Type: Grant
    Filed: February 2, 2022
    Date of Patent: December 20, 2022
    Assignee: Accutar Biotechnology Inc.
    Inventors: Yimin Qian, Wei He, Robert Luo, Jie Su, Hui Zhang, Ke Liu, Jie Fan
  • Publication number: 20220259207
    Abstract: The present disclosure relates to novel compounds that degrade Bruton's tyrosine kinase (BTK), pharmaceutical compositions containing such compounds, and their use in prevention and treatment of conditions modulated by BTK.
    Type: Application
    Filed: February 2, 2022
    Publication date: August 18, 2022
    Applicant: ACCUTAR BIOTECHNOLOGY INC.
    Inventors: Yimin Qian, Wei He, Robert Luo, JIE SU, HUI ZHANG, KE LIU, JIE FAN
  • Patent number: 9854635
    Abstract: An embodiment of the present application provides a temperature adaptive control circuit for a light emitting diode and a lighting and/or signaling apparatus. The control circuit includes: a light emitting diode load circuit unit in which one or more light emitting diodes are connected; and a temperature adaptive circuit unit comprising a positive temperature coefficient thermistor and a negative temperature coefficient thermistor connected in series, wherein the temperature adaptive circuit unit is configured such that current flowing through the one or more light emitting diodes in the light emitting diode load circuit unit is a function of sum of resistance of the positive temperature coefficient thermistor and resistance of the negative temperature coefficient thermistor. It not only can compensate the variation of the luminescent intensity with the temperature in a desired working temperature for the LEDs, but also can achieve overheating protection for the LEDs to avoid damage thereof.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: December 26, 2017
    Assignee: VALEO LIGHTING HUBEI TECHNICAL CENTER CO. LTD.
    Inventors: Dan-Danny Liu, Sylvain Yvon, Biao-Robert Luo
  • Publication number: 20170303574
    Abstract: The present invention provides edible compositions comprising a sweet taste modulator or bitter taste blocker of the present invention, food products comprising such edible compositions and methods of preparing such food products. The present invention also provides methods of reducing the amount of sugar in a food product, methods of reducing the caloric intake in a diet, and methods of enhancing sweet taste or blocking a bitter taste in a food product.
    Type: Application
    Filed: September 3, 2015
    Publication date: October 26, 2017
    Applicant: Chromocell Corporation
    Inventors: Robert Luo, Leonard McDonald, Deshou Jiang, Purvi Shah, Hao Zhou
  • Publication number: 20170164443
    Abstract: An embodiment of the present application provides a temperature adaptive control circuit for a light emitting diode and a lighting and/or signaling apparatus. The control circuit includes: a light emitting diode load circuit unit in which one or more light emitting diodes are connected; and a temperature adaptive circuit unit comprising a positive temperature coefficient thermistor and a negative temperature coefficient thermistor connected in series, wherein the temperature adaptive circuit unit is configured such that current flowing through the one or more light emitting diodes in the light emitting diode load circuit unit is a function of sum of resistance of the positive temperature coefficient thermistor and resistance of the negative temperature coefficient thermistor. It not only can compensate the variation of the luminescent intensity with the temperature in a desired working temperature for the LEDs, but also can achieve overheating protection for the LEDs to avoid damage thereof.
    Type: Application
    Filed: December 5, 2016
    Publication date: June 8, 2017
    Applicant: VALEO LIGHTING HUBEI TECHNICAL CENTER CO. LTD.
    Inventors: Dan-Danny LIU, Sylvain YVON, Biao-Robert LUO
  • Publication number: 20100234341
    Abstract: Compounds of formula (I) including pharmaceutically acceptable salts, esters, solvates and stereoisomers thereof, R1, R2 and R3 are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed.
    Type: Application
    Filed: December 4, 2007
    Publication date: September 16, 2010
    Inventors: Marion Lanier, Deborah Slee, Emily Lin, Zhiyong Robert Luo, Yongsheng Chen, Manisha Moorjani, Binh G. Vong, John Tellew